BDX Q4 2025 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q4 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.9B+8.3% YoY

Gross Profit

$2.8B47.5% margin

Operating Income

$697M11.8% margin

Net Income

$493M8.4% margin

EPS (Diluted)

$1.72

QoQ Revenue Growth

+6.9%

Cash Flow

Operating Cash Flow

$1.4B

Free Cash Flow

$1.0B

Stock-Based Comp.

$55M

Balance Sheet

Total Assets

$55.3B

Total Liabilities

$29.9B

Stockholders' Equity

$25.4B

Cash & Equivalents

$851M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.9B	$5.4B	+8.3%
Gross Profit	$2.8B	$2.5B	+12.5%
Operating Income	$697M	$622M	+12.1%
Net Income	$493M	$400M	+23.3%

Revenue Segments

Medical

$3.2B54%

Life Sciences

$1.4B23%

Interventional

$1.4B23%

Geographic Segments

UNITED STATES

$3.4B100%